Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Vaccines

Free Subscription Articles published in Infect Immun Retrieve available abstracts of 34 articles: HTML format

Single Articles

June 2022
1. DAYAO DA, Jaskiewcz J, Lee S, Oliveira BC, et al
   Development of Two Mouse Models for Vaccine Evaluation against Cryptosporidiosis.
   Infect Immun. 2022 Jun 23:e0012722. doi: 10.1128/iai.00127.
   PubMed     Abstract available
   
   
   May 2022
2. KAUR R, Pichichero M
   Lipidation of Haemophilus influenzae Antigens P6 and OMP26 Improves Immunogenicity and Protection against Nasopharyngeal Colonization and Ear Infection.
   Infect Immun. 2022;90:e0067821.
   PubMed     Abstract available
   
   
   January 2022
3. ZHOU Z, Tian Q, Wang L, Zhong G, et al
   Chlamydia deficient in plasmid-encoded glycoprotein 3 (pGP3) as an attenuated live oral vaccine.
   Infect Immun. 2022 Jan 31:IAI0047221. doi: 10.1128/IAI.00472.
   PubMed     Abstract available
   
   
   
4. CHAN WY, Entwisle C, Ercoli G, Ramos-Sevillano E, et al
   Correction for Chan et al., "A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Streptococcus pneumoniae Challenge".
   Infect Immun. 2022;90:e0063921.
   PubMed    
   
   
   
5. CHAN WY, Entwisle C, Ercoli G, Ramos-Sevillano E, et al
   Corrected and Republished from: "A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Streptococcus pneumoniae Challenge".
   Infect Immun. 2022;90:e0084618a.
   PubMed     Abstract available
   
   
   
6. SAKATANI H, Kono M, Nanushaj D, Murakami D, et al
   A novel pneumococcal surface protein K of nonencapsulated Streptococcus pneumoniae promotes transmission among littermates in an infant mouse model with influenza A virus co-infection.
   Infect Immun. 2022 Jan 3:iai0062221. doi: 10.1128/iai.00622.
   PubMed     Abstract available
   
   
   November 2021
7. HALL JM, Bitzer GJ, DeJong MA, Kang J, et al
   Mucosal Immunization with DTaP Confers Protection against Bordetella pertussis Infection and Cough in Sprague-Dawley Rats.
   Infect Immun. 2021;89:e0034621.
   PubMed     Abstract available
   
   
   October 2021
8. TEIXEIRA AF, Gillespie A, Yirsaw A, Britton E, et al
   Identification of leptospiral protein antigens recognized by WC1(+) gammadelta T cell subsets as target for development of recombinant vaccines.
   Infect Immun. 2021 Oct 25:IAI0049221. doi: 10.1128/IAI.00492.
   PubMed     Abstract available
   
   
   
9. GUO M, Guo X, Zhang C, Zhu S, et al
   A novel pneumococcal protein-polysaccharide conjugate vaccine based on biotin-streptavidin.
   Infect Immun. 2021 Oct 25:IAI0035221. doi: 10.1128/IAI.00352.
   PubMed     Abstract available
   
   
   
10. LI P, Wang X, Sun X, Cimino J, et al
    Recombinant Pseudomonas Bionanoparticles Induce Protection against Pneumonic Pseudomonas aeruginosa Infection.
    Infect Immun. 2021;89:e0039621.
    PubMed     Abstract available
    
    
    September 2021
11. WOLF MA, Boehm DT, DeJong MA, Wong TY, et al
    Erratum for Wolf et al., "Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice".
    Infect Immun. 2021;89:e0028521.
    PubMed    
    
    
    July 2021
12. DANIEL S, Pichugin A, Torano H, Renn JP, et al
    Plasmodium pre-erythrocytic vaccine antigens enhance sterile protection in mice induced by circumsporozoite protein.
    Infect Immun. 2021 Jul 26:IAI0016521. doi: 10.1128/IAI.00165.
    PubMed     Abstract available
    
    
    
13. HIGGINSON EE, Panda A, Toapanta FR, Terzi MC, et al
    Immunogenicity and efficacy of live-attenuated Salmonella Typhimurium vaccine candidate CVD 1926 in a rhesus macaque model of gastroenteritis.
    Infect Immun. 2021 Jul 26:IAI0008721. doi: 10.1128/IAI.00087.
    PubMed     Abstract available
    
    
    
14. CHAC D, Bhuiyan TR, Saha A, Alam MM, et al
    The gut microbiota and development of Vibrio cholerae-specific long-term memory B cells in adults after whole-cell killed oral cholera vaccine.
    Infect Immun. 2021 Jul 6:IAI0021721. doi: 10.1128/IAI.00217.
    PubMed     Abstract available
    
    
    
15. ZHANG QF, Jiang TT, Mao X, Kim JD, et al
    Development of combination vaccine conferring optimal protection against six pore-forming toxins of Staphylococcus aureus.
    Infect Immun. 2021 Jul 6:IAI0034221. doi: 10.1128/IAI.00342.
    PubMed     Abstract available
    
    
    June 2021
16. REEDER SM, Bah MA, Tursi NJ, Brooks RC, et al
    Strategic variants of CSP delivered as SynDNA vaccines demonstrate heterogeneity of immunogenicity and protection from Plasmodium infection in a murine model.
    Infect Immun. 2021 Jun 21:IAI0072820. doi: 10.1128/IAI.00728.
    PubMed     Abstract available
    
    
    May 2021
17. CLARK JR, Maresso AM
    Comparative Pathogenomics of Escherichia coli: Polyvalent Vaccine Target Identification Through Virulome Analysis.
    Infect Immun. 2021 May 3. pii: IAI.00115-21. doi: 10.1128/IAI.00115.
    PubMed     Abstract available
    
    
    April 2021
18. SEO H, Garcia C, Ruan X, Duan Q, et al
    Preclinical characterization of immunogenicity and efficacy against diarrhea from MecVax, a multivalent enterotoxigenic E. coli vaccine candidate.
    Infect Immun. 2021 Apr 19. pii: IAI.00106-21. doi: 10.1128/IAI.00106.
    PubMed     Abstract available
    
    
    
19. ALQAHTANI M, Ma Z, Fantone K, Malik M, et al
    Aim2 and Nlrp3 Are Dispensable For Vaccine-Induced Immunity Against Francisella tularensis Live Vaccine Strain.
    Infect Immun. 2021 Apr 19. pii: IAI.00134-21. doi: 10.1128/IAI.00134.
    PubMed     Abstract available
    
    
    February 2021
20. HALL ER, O'Dowd A, Rollenhagen JE, Espinoza N, et al
    Establishment and Validation of Pathogenic CS17(+) and CS19(+) Enterotoxigenic Escherichia coli Challenge Models in the New World Primate Aotus nancymaae.
    Infect Immun. 2021;89.
    PubMed     Abstract available
    
    
    January 2021
21. RODRIGUES ML
    The benefits of exporting: engineered extracellular vesicles as promising vaccine candidates against enteric fever.
    Infect Immun. 2021 Jan 19. pii: IAI.00001-21. doi: 10.1128/IAI.00001.
    PubMed     Abstract available
    
    
    December 2020
22. WANG Y, Li Z, Wu S, Fleming J, et al
    Systematic evaluation of Mycobacterium tuberculosis proteins for antigenic properties identifies Rv1485 and Rv1705c as potential protective subunit vaccine candidates.
    Infect Immun. 2020 Dec 14. pii: IAI.00585-20. doi: 10.1128/IAI.00585.
    PubMed     Abstract available
    
    
    
23. GASPERINI G, Alfini R, Arato V, Mancini F, et al
    Salmonella Paratyphi A outer membrane vesicles displaying Vi polysaccharide as multivalent vaccine against enteric fever.
    Infect Immun. 2020 Dec 14. pii: IAI.00699-20. doi: 10.1128/IAI.00699.
    PubMed     Abstract available
    
    
    
24. WOLF MA, Boehm DT, DeJong MA, Wong TY, et al
    Intranasal immunization with acellular pertussis vaccines results in long-term immunity to Bordetella pertussis in mice.
    Infect Immun. 2020 Dec 14. pii: IAI.00607-20. doi: 10.1128/IAI.00607.
    PubMed     Abstract available
    
    
    November 2020
25. SEN-KILIC E, Blackwood CB, Huckaby AB, Horspool AM, et al
    Defining the mechanistic correlates of protection conferred by whole-cell vaccination against Pseudomonas aeruginosa acute murine pneumonia.
    Infect Immun. 2020 Nov 16. pii: IAI.00451-20. doi: 10.1128/IAI.00451.
    PubMed     Abstract available
    
    
    
26. SHILLOVA N, Howe SE, Hyseni B, Ridgell D, et al
    Chlamydia-specific IgA secretion in the female reproductive tract induced via per-oral immunization confers protection against primary Chlamydia challenge.
    Infect Immun. 2020 Nov 2. pii: IAI.00413-20. doi: 10.1128/IAI.00413.
    PubMed     Abstract available
    
    
    October 2020
27. O'DOWD A, Maciel M Jr, Poole ST, Jobling MG, et al
    Evaluation of the Immunogenicity and Protective Efficacy of an Enterotoxigenic Escherichia coli CFA/I Adhesin-Heat-Labile Toxin Chimera.
    Infect Immun. 2020;88.
    PubMed     Abstract available
    
    
    
28. VAZ MJ, Purrier SA, Bonakdar M, Chamby AB, et al
    The impact of circulating antibody on Group B Streptococcus intestinal colonization and invasive disease.
    Infect Immun. 2020 Oct 19. pii: IAI.00348-20. doi: 10.1128/IAI.00348.
    PubMed     Abstract available
    
    
    September 2020
29. TZENG YL, Giuntini S, Berman Z, Sannigrahi S, et al
    Neisseria meningitidis urethritis outbreak isolates express a novel factor H binding protein allele that is a potential target of MenB directed meningococcal vaccines.
    Infect Immun. 2020 Sep 21. pii: IAI.00462-20. doi: 10.1128/IAI.00462.
    PubMed     Abstract available
    
    
    
30. NAIMI WA, Gumpf JJ, Green RS, Izac JR, et al
    Immunization against Anaplasma phagocytophilum Adhesin Binding Domains Confers Protection against Infection in the Mouse Model.
    Infect Immun. 2020;88.
    PubMed     Abstract available
    
    
    April 2020
31. WANG X, Singh AK, Zhang X, Sun W, et al
    Induction of Protective Antiplague Immune Responses by Self-Adjuvanting Bionanoparticles Derived from Engineered Yersinia pestis.
    Infect Immun. 2020;88.
    PubMed     Abstract available
    
    
    
32. MARCINKIEWICZ AL, Lieknina I, Yang X, Lederman PL, et al
    The Factor H-Binding Site of CspZ as a Protective Target against Multistrain, Tick-Transmitted Lyme Disease.
    Infect Immun. 2020;88.
    PubMed     Abstract available
    
    
    
33. KULAPPU ARACHCHIGE SN, Young ND, Shil PK, Legione AR, et al
    Differential Response of the Chicken Trachea to Chronic Infection with Virulent Mycoplasma gallisepticum Strain Ap3AS and Vaxsafe MG (Strain ts-304): a Transcriptional Profile.
    Infect Immun. 2020;88.
    PubMed     Abstract available
    
    
    
34. DADELAHI AS, Lacey CA, Chambers CA, Ponzilacqua-Silva B, et al
    B Cells Inhibit CD4(+) T Cell-Mediated Immunity to Brucella Infection in a Major Histocompatibility Complex Class II-Dependent Manner.
    Infect Immun. 2020;88.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: